BioCardia, Inc. (NASDAQ:BCDA) Q4 2023 Earnings Call Transcript
BioCardia, Inc. beats earnings expectations. Reported EPS is $-0.09, expectations were $-0.11.
Source: insidermonkey.com
Stay updated with breaking news from Morph Access Innovations. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
BioCardia, Inc. beats earnings expectations. Reported EPS is $-0.09, expectations were $-0.11.
BioCardia Reports Fourth Quarter and Full Year 2023 Business Highlights and Financial Results March 27, 2024 BioCardia®, Inc. [Nasdaq: BCDA], a developer of...